Intimation of Reclassification of Promoters under Regulations 31A of SEBI (LODR) Regulations, 2015

Date:24th August, 2026 BSE Limited Listing Compliance Monitoring Cell, 24th Floor, P.J. Towers, Dalal Street, Mumbai - 400 001. Dear Sir/Madam, SCRIPT CODE: 540359 SUB: INTIMATION UNDER REGULATION 30, 31A(5) & 31A(10) OF SEBI (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2015 REGARDING PROPOSED CLASSIFICATION OF NEW PROMOTERS AND RECLASSIFICATION OF EXISTING PROMOTERS Pursuant to Regulation 31A(5) and Regulation 31A(10) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI LODR Regulations"), we hereby inform you that following person as mentioned below: 1. Dhiren Chandulal Shah (“Acquirer 1”) 2. Sunil Chinubhai Shah (“Acquirer 2”) (hereinafter collectively referred to as the "Acquirers") 3. Dhairya Dhiren Shah (“PAC 1”) 4. Hiren Pravin Doshi (“PAC 2”) 5. Sheetal Hiren Doshi (“PAC 3”) 6. Nirmal Sunilbhai Shah (“PAC 4”) 7. Rupa Sunil Shah (“PAC 5”) 8. Vijaykumar Natvarlal Shiyani (“PAC 6”) 9. Kamlesh Natvarlal Shiyani (“PAC 7”) 10. Abhay Chinubhai Shah (“PAC 8”) 11. Umang Alkesh Gosalia (“PAC 9”) 12. Meena Alkesh Gosalia (“PAC 10”) (hereinafter collectively referred to as the "PACs") had made an Open Offer to the Public Shareholders of Parmax Pharma Limited in accordance with the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 and subsequent amendments thereto. Out of which, the Acquirers, PAC 1, PAC 2, PAC 3, PAC 4, PAC 6 and PAC7 had entered into a Share Purchase Agreement dated June 08, 2026 (“Share Purchase Agreement”), with the following erstwhile Promoters / Sellers for acquisition of 11,52,450 Equity Shares aggregating to 30.80% of the Equity Share Capital of the Company, the details of which are as under: Sr Name of the Erstwhile Promoters/ Selling Total holdings Percentage of holdings No Shareholders 1. Alkesh Mahasukhlal Gopani 6,70,380 17.92% 2. Vipul Mahasukhlal Gopani 4,81,370 12.87% 3. Pravina Mahasukh Gopani 700 0.02% Total 11,52,450 30.80% Upon successful completion of the Open Offer, transfer of shares pursuant to the Share Purchase Agreement and in compliance with the terms of the Open Offer, the aforesaid Acquirers, PAC 2 and PAC 9 shall be classified as Promoters and PAC 1, PAC 3, PAC 4, PAC 5, PAC 6, PAC 7, PAC 8 and PAC 10 shall be classified as the members of the Promoter Group of the Company in accordance with Regulation 31A(10) of the SEBI LODR Regulations and the erstwhile Promoters seeking reclassification shall be reclassified under the Public Category in terms of Regulation 31A(5) of the SEBI LODR Regulations. Further, in addition to the intention letters received from the Sellers pursuant to the Open Offer, the Company has also received undertakings from the erstwhile promoters seeking reclassification confirming compliance with the conditions as specified under clauses (b) and (c)(ii)&(iii) of sub-regulation (3) of Regulation 31A of SEBI LODR Regulations, inter-alia confirming that: Clause (b) of sub-regulation (3) of Regulation 31A of SEBI LODR Regulations: the promoter(s) seeking re-classification and persons related to the promoter(s) seeking re-classification shall not: i. together, holds more than ten percent of the total voting rights in the listed entity; ii. exercise control over the affairs of the listed entity directly or indirectly; iii. have any special rights with respect to the listed entity through formal or informal arrangements including through any shareholder agreements; iv. be represented on the board of directors (including not having a nominee director) of the listed entity; v. act as key managerial personnel in the listed entity; vi. be a ‘wilful defaulter’ as per the Reserve Bank of India Guidelines; vii. be a fugitive economic offender. Clause (c)(ii)&(iii) of sub-regulation (3) of Regulation 31A of SEBI LODR Regulations: the listed entity shall: ii. not have trading in its shares suspended by the stock exchanges; iii. not have any outstanding dues to the Board, the stock exchanges or the depositories. This is for your information and records. Thanking you, Yours faithfully, For PARMAX PHARMA LIMITED Umang Gosalia Managing Director DIN: 05153830